Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jamie N. Anastas
Observed names:
Anastas, Jamie N.,
J N Anastas,
Jamie Anastas,
Jamie N Anastas
Institutions:
Baylor College of Medicine,
Hunter Medical Research Institute,
Dan L Duncan Comprehensive Cancer Center
Observed institutions:
Boston Children's Hospital,
Howard Hughes Medical Institute,
Harvard University,
Baylor College of Medicine,
University of Washington,
Hunter Medical Research Institute,
Dan L Duncan Comprehensive Cancer Center
show all 7
ORCID:
0000-0002-5317-5352
Observed ORCID:
0000-0002-5317-5352
OpenAlex ID:
A5079320246
Works
54
Awards
3
WNT signalling pathways as therapeutic targets in cancer
2012
·
Jamie N. Anastas
, Randall T. Moon
·
Nature reviews. Cancer
·
2,095
Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation
2017
·
Gareth R. Willis
, Angeles Fernandez-Gonzalez
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
657
Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG
2019
·
Jamie N. Anastas
, Barry M. Zee
, et al.
·
Cancer Cell
·
212
WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors
2014
·
Jamie N. Anastas
, Rima M. Kulikauskas
, et al.
·
Journal of Clinical Investigation
·
198
PDF
New Regulators of Wnt/β-Catenin Signaling Revealed by Integrative Molecular Screening
2008
·
Michael B. Major
, Brian S. Roberts
, et al.
·
Science Signaling
·
169
A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression
2011
·
J N Anastas
, T L Biechele
, et al.
·
Oncogene
·
152
PDF
Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling
2011
·
Jason D. Berndt
, Atsushi Aoyagi
, et al.
·
The Journal of Cell Biology
·
109
PDF
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors
2024
·
Frank Y. Lin
, Austin Stuckert
, et al.
·
Journal of Clinical Oncology
·
97
PDF
Histone Lysine Demethylase Inhibitors
2016
·
Ashwini Jambhekar
, Jamie N. Anastas
, et al.
·
Cold Spring Harbor Perspectives in Medicine
·
84
PDF
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma
2022
·
Eshini Panditharatna
, Joana G. Marques
, et al.
·
Cancer Discovery
·
71
WLS inhibits melanoma cell proliferation through the β‐catenin signalling pathway and induces spontaneous metastasis
2012
·
Pei‐Tzu Yang
, Jamie N. Anastas
, et al.
·
EMBO Molecular Medicine
·
38
RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma
2020
·
Fangfang Jiao
, Ze Li
, et al.
·
Science Advances
·
33
Histone Serotonylation: Can the Brain Have “Happy” Chromatin?
2019
·
Jamie N. Anastas
, Yang Shi
·
Molecular Cell
·
30
PDF
A road map for the treatment of pediatric diffuse midline glioma
2023
·
Carl Koschmann
, Wajd N. Al-Holou
, et al.
·
Cancer Cell
·
29
Applying single cell multi-omic analyses to understand treatment resistance in pediatric high grade glioma
2023
·
Rebecca L. Murdaugh
, Jamie N. Anastas
·
Frontiers in Pharmacology
·
8
PDF
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
2023
·
Linda Zhang
, Joanne I. Hsu
, et al.
·
eLife
·
5
PDF
Functional crosstalk between WNT signaling and tyrosine kinase signaling in cancer
2016
·
Jamie N. Anastas
·
Seminars in Oncology
·
3
Targeting SAGA/ATAC complexes disrupts chromatin regulation and cholesterol metabolism in diffuse midline glioma
2026
·
Rosemary U. Richard
, Caitlin L. Bagnetto
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
Wnt Signaling in Melanoma
2014
·
Jamie N. Anastas
, Andy J. Chien
·
Wiley eBooks
·
2
Cutting through complexity: Spatial multi-omics in the fight against DIPG/DMG
2026
·
Tuan Vo
, Clara Savary
, et al.
·
Neuro-Oncology Pediatrics
·
1
Elongin B orchestrates chromatin and transcriptional programs in H3K27M-mutant diffuse midline glioma
2026
·
Alan L. Jiao
, Rebecca L. Murdaugh
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
Immu-18. Enhancing Gd2.car T Cell Therapy for Diffuse Midline Glioma With Lsd1 and Hdac Inhibitors
2024
·
Rebecca L Murdaugh
, Meghan Shekar
, et al.
·
Neuro-Oncology
·
1
PDF
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
2024
·
Linda Zhang
, Joanne I. Hsu
, et al.
·
eLife
·
1
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
2023
·
Linda Zhang
, Joanne I. Hsu
, et al.
·
eLife
·
1
H3 dopaminylation and CaMKII modulate diffuse midline glioma response to CDK9 inhibition
2026
·
Rebecca L. Murdaugh
, Brittany R. Eberl
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Show more works
View as search
Works count:
54
Citation count:
3,999
H-index:
14
I10-index:
14
Year
Topic
Type